Skip to main content
HuBei NengTer Technology CO.,Ltd logo

HuBei NengTer Technology CO.,Ltd — Investor Relations & Filings

Ticker · 002102 ISIN · CNE000001Q28 Shenzhen Stock Exchange Manufacturing
Filings indexed 3,004 across all filing types
Latest filing 2021-08-23 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 002102

About HuBei NengTer Technology CO.,Ltd

https://www.guanfu.com

HuBei NengTer Technology CO.,Ltd specializes in the research, development, and large-scale production of fine chemicals and pharmaceutical intermediates. The company is a prominent global supplier of key intermediates for Vitamin E, including trimethylhydroquinone and isophytol, utilizing proprietary catalytic technologies. Its product portfolio also encompasses high-end chiral chemicals and intermediates for cardiovascular medications, such as statins. HuBei NengTer focuses on technological innovation in chemical synthesis, aiming for high-efficiency and environmentally sustainable manufacturing processes. The company serves international markets, providing essential raw materials for the pharmaceutical, nutraceutical, and animal nutrition sectors.

Recent filings

Filing Released Lang Actions
2021年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled '2021 年半年度报告摘要' which translates to '2021 Half-Year Report Summary'. It contains detailed financial data for the half-year period, including revenue, net profit, earnings per share, and asset information. It also discusses company operations, shareholder information, and significant events during the reporting period. The presence of comprehensive financial metrics and operational details indicates this is a substantive financial report for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). The document length is over 5,000 characters and contains actual financial data, not just an announcement or certification. Hence, the classification is IR with high confidence. H1 2021
2021-08-23 Chinese
独立董事关于调整公司之子公司2021年度日常关联交易预计的事前同意函
Regulatory Filings Classification · 95% confidence The document is a letter from independent directors providing prior consent regarding the adjustment of the company's subsidiary's 2021 daily related-party transaction estimates. It references compliance with Chinese securities regulations and internal company rules. The document is short (824 characters) and is a formal opinion or consent letter rather than a full report or financial statement. It does not contain financial data or detailed financial analysis. It is not an announcement of voting results, management changes, or a regulatory filing per se, but a formal independent director opinion letter related to governance and compliance. Given the nature and length, it fits best under Regulatory Filings (RNS) as a compliance-related document that does not fit other categories.
2021-08-23 Chinese
2021年半年度财务报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as a 2021 semi-annual financial report (2021 年半年度财务报告) for Guanfu Holdings Co., Ltd. It contains detailed financial statements including the balance sheet (资产负债表), income statement (利润表), cash flow statement (现金流量表), and changes in shareholders' equity (股东权益变动表) for the period ending June 30, 2021. The presence of comprehensive financial data and analysis for a half-year period indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data rather than just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2021
2021-08-23 Chinese
半年报董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 37th meeting of the 6th Board of Directors of the company, including approvals for credit facilities, guarantees, and other financial authorizations. It includes voting results and mentions that these matters will be submitted to the 2021 third extraordinary shareholders meeting for approval. The document is not a financial report itself but a board meeting resolution announcement. It does not contain financial statements or detailed financial analysis, nor is it a transcript or presentation. It is not a simple announcement of a report publication but a substantive board decision document. Therefore, it fits best under Board/Management Information (MANG).
2021-08-23 Chinese
关于暂不召开公司2021年第三次临时股东大会的的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding the decision to postpone the convening of its 2021 third extraordinary general meeting of shareholders due to the COVID-19 pandemic. It discusses board resolutions and authorizations related to the timing and arrangements of the meeting but does not contain any financial statements, detailed financial data, or report content. The document is short (1066 characters) and serves as a notification about meeting scheduling changes rather than a report or detailed filing. Therefore, it fits best into the category of Regulatory Filings (RNS), which is the fallback for miscellaneous announcements that do not fit other categories.
2021-08-23 Chinese
关于争取撤销风险警示所采取的措施及有关工作进展情况的公告
Legal Proceedings Report Classification · 95% confidence The document is a detailed announcement from a company regarding measures taken to remove a risk warning and updates on related work progress. It includes extensive information about legal disputes, lawsuits, and financial risks related to the company's original controlling shareholder's violations. The document is lengthy (over 14,000 characters) and contains substantive content about legal proceedings and risk management, not just a brief notice or a certification. It does not present financial statements or quarterly results, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a call transcript, capital update, or management change announcement. The focus on lawsuits, disputes, and regulatory risk matters aligns with the definition of a Legal Proceedings Report (LTR). Therefore, the document should be classified as a Legal Proceedings Report (LTR).
2021-08-16 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.